In a model including treatment with insulin secretagogues metformin and insulin for at least 36 months during the previous 10 years, no significant association was observed between bone fractures and medications. In an alternative model considering treatments at the time of fracture, insulin treatment was significantly associated with bone fractures in men (OR 3.20 [95% CI 1.32-7.74]) but not in women (1.41 [0.73-2.73]).
Bone fractures and hypoglycaemic treatment in type 2 diabetic patients: a case-control study / M. MONAMI; B. CRESCI; A. COLOMBINI; L. PALA; D. BALZI; F. GORI; V. CHIASSERINI; N. MARCHIONNI; C. ROTELLA; E. MANNUCCI. - In: DIABETES CARE. - ISSN 0149-5992. - ELETTRONICO. - (2007), pp. 199-203.
Bone fractures and hypoglycaemic treatment in type 2 diabetic patients: a case-control study.
N. MARCHIONNI;ROTELLA, CARLO MARIA;MANNUCCI, EDOARDO
2007
Abstract
In a model including treatment with insulin secretagogues metformin and insulin for at least 36 months during the previous 10 years, no significant association was observed between bone fractures and medications. In an alternative model considering treatments at the time of fracture, insulin treatment was significantly associated with bone fractures in men (OR 3.20 [95% CI 1.32-7.74]) but not in women (1.41 [0.73-2.73]).I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.